PD-Rx Pharmaceuticals, Inc. is recalling approximately 6,641 bottles of Doxycycline Hyclate USP Tablets (100 mg), an antibiotic medication. The recall was initiated because the tablets failed dissolution testing, which means the medication may not dissolve properly in the body as intended. These products were repackaged from West-Ward Pharmaceutical Corp. lots and distributed nationwide in various bottle sizes ranging from 2-count to 400-count containers.
When a medication fails dissolution specifications, it may not be absorbed correctly by the body, potentially leading to a lower-than-intended dose. This can reduce the effectiveness of the antibiotic in treating bacterial infections.
Contact healthcare provider or pharmacist and return for refund.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.